Miao Dai
13Patents
7h-index
56Co-inventors
65Inventor score
Filing activity: Apr 22, 2002 → Sep 7, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8536168B2 | Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway | Chemistry; Metallurgy | 29 | Active |
| US8546336B2 | SMAC peptidometics useful as IAP inhibitors | Chemistry; Metallurgy | 12 | Active |
| US6660752B2 | 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists | Chemistry; Metallurgy | 12 | Expired |
| US7091228B2 | Preparation and use of aryl alkyl acid derivatives for the treatment of obesity | Chemistry; Metallurgy | 8 | Expired |
| US8410264B2 | Heterocyclic oxime compounds | Human Necessities | 8 | Active |
| US8044209B2 | Pyrrolydine derivatives as IAP inhibitors | Human Necessities | 8 | Active |
| US8552003B2 | (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their uses | Chemistry; Metallurgy | 7 | Active |
| US8497368B2 | Heterocyclic hydrazone compounds | Human Necessities | 2 | Active |
| US8507676B2 | Heterocyclic oxime compounds | Human Necessities | 2 | Active |
| US7968576B2 | Preparation and use of aryl alkyl acid derivatives for the treatment of obesity | Chemistry; Metallurgy | 1 | Active |
| US6919371B2 | 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists | Chemistry; Metallurgy | 1 | Expired |
| US7423156B2 | Preparation and use of aryl alkyl acid derivatives for the treatment of obesity | Chemistry; Metallurgy | 0 | Expired |
| US8013166B2 | Preparation and use of aryl alkyl acid derivatives for the treatment of obesity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.